The potential future role of extensive lipid lowering in ACS patients with the use of PCSK9 inhibitors: Early bird catches the worm.
Kyriakos DimitriadisNikolaos PyrpyrisKonstantinos TsioufisPublished in: European heart journal. Cardiovascular pharmacotherapy (2023)